76 related articles for article (PubMed ID: 31261874)
41. Antihypertensive drug telmisartan inhibits cell proliferation of gastrointestinal stromal tumor cells in vitro.
Kobara H; Fujihara S; Iwama H; Matsui T; Fujimori A; Chiyo T; Tingting S; Kobayashi N; Nishiyama N; Yachida T; Tadokoro T; Oura K; Tani J; Fujita K; Nomura T; Yoneyama H; Morishita A; Okano K; Suzuki Y; Mori H; Masaki T
Mol Med Rep; 2020 Aug; 22(2):1063-1071. PubMed ID: 32626983
[TBL] [Abstract][Full Text] [Related]
42. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Bray F; Ferlay J; Soerjomataram I; Siegel RL; Torre LA; Jemal A
CA Cancer J Clin; 2018 Nov; 68(6):394-424. PubMed ID: 30207593
[TBL] [Abstract][Full Text] [Related]
43. Telmisartan inhibits NSCLC A549 cell proliferation and migration by regulating the PI3K/AKT signaling pathway.
Zhang S; Wang Y
Oncol Lett; 2018 Apr; 15(4):5859-5864. PubMed ID: 29552215
[TBL] [Abstract][Full Text] [Related]
44. Angiotensin receptor blocker telmisartan inhibits cell proliferation and tumor growth of cholangiocarcinoma through cell cycle arrest.
Samukawa E; Fujihara S; Oura K; Iwama H; Yamana Y; Tadokoro T; Chiyo T; Kobayashi K; Morishita A; Nakahara M; Kobara H; Mori H; Okano K; Suzuki Y; Himoto T; Masaki T
Int J Oncol; 2017 Dec; 51(6):1674-1684. PubMed ID: 29075786
[TBL] [Abstract][Full Text] [Related]
45. Telmisartan inhibits hepatocellular carcinoma cell proliferation in vitro by inducing cell cycle arrest.
Oura K; Tadokoro T; Fujihara S; Morishita A; Chiyo T; Samukawa E; Yamana Y; Fujita K; Sakamoto T; Nomura T; Yoneyama H; Kobara H; Mori H; Iwama H; Okano K; Suzuki Y; Masaki T
Oncol Rep; 2017 Nov; 38(5):2825-2835. PubMed ID: 29048654
[TBL] [Abstract][Full Text] [Related]
46. MicroRNA-765 Enhances the Anti-Angiogenic Effect of CDDP via APE1 in Osteosarcoma.
Liang W; Wei X; Li Q; Dai N; Li CY; Deng Y; Jiang X; Tan XR; Dai XY; Li MX; Xu CX; Wang D; Zhong ZY
J Cancer; 2017; 8(9):1542-1551. PubMed ID: 28775773
[TBL] [Abstract][Full Text] [Related]
47. Oesophageal cancer.
Smyth EC; Lagergren J; Fitzgerald RC; Lordick F; Shah MA; Lagergren P; Cunningham D
Nat Rev Dis Primers; 2017 Jul; 3():17048. PubMed ID: 28748917
[TBL] [Abstract][Full Text] [Related]
48. Dysregulation of Rab37-Mediated Cross-talk between Cancer Cells and Endothelial Cells via Thrombospondin-1 Promotes Tumor Neovasculature and Metastasis.
Tzeng HT; Tsai CH; Yen YT; Cheng HC; Chen YC; Pu SW; Wang YS; Shan YS; Tseng YL; Su WC; Lai WW; Wu LW; Wang YC
Clin Cancer Res; 2017 May; 23(9):2335-2345. PubMed ID: 28151721
[No Abstract] [Full Text] [Related]
49. Esophageal Cancer.
Short MW; Burgers KG; Fry VT
Am Fam Physician; 2017 Jan; 95(1):22-28. PubMed ID: 28075104
[TBL] [Abstract][Full Text] [Related]
50. The angiotensin II type 1 receptor antagonist telmisartan inhibits cell proliferation and tumor growth of esophageal adenocarcinoma via the AMPKα/mTOR pathway in vitro and in vivo.
Fujihara S; Morishita A; Ogawa K; Tadokoro T; Chiyo T; Kato K; Kobara H; Mori H; Iwama H; Masaki T
Oncotarget; 2017 Jan; 8(5):8536-8549. PubMed ID: 28052030
[TBL] [Abstract][Full Text] [Related]
51. Angiotensin II type 1 receptor blocker telmisartan induces apoptosis and autophagy in adult T-cell leukemia cells.
Kozako T; Soeda S; Yoshimitsu M; Arima N; Kuroki A; Hirata S; Tanaka H; Imakyure O; Tone N; Honda S; Soeda S
FEBS Open Bio; 2016 May; 6(5):442-60. PubMed ID: 27419050
[TBL] [Abstract][Full Text] [Related]
52. Telmisartan prevents proliferation and promotes apoptosis of human ovarian cancer cells through upregulating PPARγ and downregulating MMP‑9 expression.
Pu Z; Zhu M; Kong F
Mol Med Rep; 2016 Jan; 13(1):555-9. PubMed ID: 26548340
[TBL] [Abstract][Full Text] [Related]
53. Epithelial membrane protein 3 functions as an oncogene and is regulated by microRNA-765 in primary breast carcinoma.
Hong XC; Fen YJ; Yan GC; Hong H; Yan CH; Bing LW; Zhong YH
Mol Med Rep; 2015 Nov; 12(5):6445-50. PubMed ID: 26398721
[TBL] [Abstract][Full Text] [Related]
54. Antiproliferative and apoptotic effects of telmisartan in human colon cancer cells.
Lee LD; Mafura B; Lauscher JC; Seeliger H; Kreis ME; Gröne J
Oncol Lett; 2014 Dec; 8(6):2681-2686. PubMed ID: 25360175
[TBL] [Abstract][Full Text] [Related]
55. miRNA in hepatocellular carcinoma.
Morishita A; Masaki T
Hepatol Res; 2015 Jan; 45(2):128-41. PubMed ID: 25040738
[TBL] [Abstract][Full Text] [Related]
56. ERBB3 knockdown induces cell cycle arrest and activation of Bak and Bax-dependent apoptosis in colon cancer cells.
Lee H; Lee H; Chin H; Kim K; Lee D
Oncotarget; 2014 Jul; 5(13):5138-52. PubMed ID: 24970817
[TBL] [Abstract][Full Text] [Related]
57. Prognostic impact of renin-angiotensin system blockade in esophageal squamous cell carcinoma.
Chen YH; Huang CH; Lu HI; Chen CH; Huang WT; Hsieh MJ; Rau KM; Chang AY; Lin WC; Li SH
J Renin Angiotensin Aldosterone Syst; 2015 Dec; 16(4):1185-92. PubMed ID: 24961505
[TBL] [Abstract][Full Text] [Related]
58. Telmisartan induces growth inhibition, DNA double-strand breaks and apoptosis in human endometrial cancer cells.
Koyama N; Nishida Y; Ishii T; Yoshida T; Furukawa Y; Narahara H
PLoS One; 2014; 9(3):e93050. PubMed ID: 24667764
[TBL] [Abstract][Full Text] [Related]
59. Telmisartan exerts anti-tumor effects by activating peroxisome proliferator-activated receptor-γ in human lung adenocarcinoma A549 cells.
Li J; Chen L; Yu P; Liu B; Zhu J; Yang Y
Molecules; 2014 Mar; 19(3):2862-76. PubMed ID: 24603556
[TBL] [Abstract][Full Text] [Related]
60. Oesophageal carcinoma.
Pennathur A; Gibson MK; Jobe BA; Luketich JD
Lancet; 2013 Feb; 381(9864):400-12. PubMed ID: 23374478
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
